The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as the underwriter for the Offering (the “Underwriter”). Ortoli Rosenstadt LLP acted as U.S. counsel to the ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

Neglected Tropical Diseases (NTDs) remain a significant health burden in tropical and subtropical regions, with limited ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...